Plain-English translation of NCT06955936 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a medical device called Efferon CT that cleans your blood to remove harmful inflammatory molecules when your heart suddenly fails after a heart attack. The device works like a filter during a special blood treatment session. Researchers believe this treatment, added to standard heart attack care, may help patients recover better and survive longer.
Heart failure from a heart attack is life-threatening, with very high death rates even with the best current treatments. Similar blood-cleaning devices have shown promise in early studies by reducing inflammation and improving survival, so researchers want to test whether this medication can do the same.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive either standard heart attack treatment alone, or standard treatment plus one session of blood cleaning with the Efferon CT device. The treatment session lasts at least 4 hours and is performed in a hospital intensive care setting. Doctors will monitor your heart function, blood work, and overall recovery to see if adding this blood-cleaning treatment helps you improve.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Russia